The document summarizes the findings of a social media audit conducted by Ogilvy to analyze how pharmaceutical companies are using social media. It identified three groups - those connecting the dots by fully integrating social media, those dabbling but not maintaining constant activity, and those still searching for a strategy. The audit evaluated companies' social presence, activity, engagement, network simplicity, content virality, and community size across key social networks. It encourages pharmaceutical companies to better connect with audiences by being brave, personal, timely, prepared, instructive, and moving social media throughout their marketing strategy in order to stand out from competitors.